SAMD9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.471200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.527400E-01
Normal-vs-Stage2
7.334600E-01
Normal-vs-Stage3
3.523000E-01
Normal-vs-Stage4
8.896800E-01
Stage1-vs-Stage2
2.973000E-01
Stage1-vs-Stage3
3.979400E-01
Stage1-vs-Stage4
7.721200E-01
Stage2-vs-Stage3
1.601780E-01
Stage2-vs-Stage4
5.556400E-01
Stage3-vs-Stage4
3.988600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.170200E-01
Normal-vs-AfricanAmerican
9.767600E-01
Normal-vs-Asian
4.093800E-01
Caucasian-vs-AfricanAmerican
9.150800E-01
Caucasian-vs-Asian
1.220050E-01
AfricanAmerican-vs-Asian
2.618800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.087800E-01
Normal-vs-Female
9.254400E-01
Male-vs-Female
4.169600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.360800E-01
Normal-vs-Age(41-60Yrs)
5.474200E-01
Normal-vs-Age(61-80Yrs)
9.610800E-01
Normal-vs-Age(81-100Yrs)
7.803400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.333810E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.597000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.893430E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.574400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.044700E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.620390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.009000E-01
Normal-vs-Daily Drinker
8.056200E-01
Normal-vs-Weekly Drinker
8.465400E-01
Normal-vs-Occasional Drinker
7.749600E-01
Normal-vs-Social Drinker
9.350200E-01
Non Drinker-vs-Daily Drinker
1.488980E-01
Non Drinker-vs-Weekly Drinker
6.154200E-01
Non Drinker-vs-Occasional Drinker
9.640500E-02
Non Drinker-vs-Social Drinker
3.523600E-01
Daily Drinker-vs-Weekly Drinker
4.278000E-01
Daily Drinker-vs-Occasional Drinker
9.969200E-01
Daily Drinker-vs-Social Drinker
4.705400E-01
Weekly Drinker-vs-Occasional Drinker
3.838800E-01
Weekly Drinker-vs-Social Drinker
7.823800E-01
Occasional Drinker-vs-Social Drinker
4.624600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.600000E-01
Normal-vs-Grade 2
1.006820E-01
Normal-vs-Grade 3
2.135500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.184900E-04
Grade 1-vs-Grade 3
2.015900E-04
Grade 1-vs-Grade 4
1.600000E-01
Grade 2-vs-Grade 3
7.278200E-01
Grade 2-vs-Grade 4
1.006820E-01
Grade 3-vs-Grade 4
2.135500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.102600E-01
Normal-vs-NonDiabetic
7.604200E-01
Diabetic-vs-NonDiabetic
7.576700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.465200E-01
Normal-vs-NoPancreatitis
8.490400E-01
Pancreatitis-vs-NoPancreatitis
9.897200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.195800E-01
Normal-vs-N1
7.431000E-01
N0-vs-N1
1.360010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.069200E-01
Normal-vs-TP53-NonMutant
9.108200E-01
TP53-Mutant-vs-TP53-NonMutant
1.175640E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
